SG10201607521PA - Generation of brown adipose tissue (bat) from mesenchymal cells - Google Patents
Generation of brown adipose tissue (bat) from mesenchymal cellsInfo
- Publication number
- SG10201607521PA SG10201607521PA SG10201607521PA SG10201607521PA SG10201607521PA SG 10201607521P A SG10201607521P A SG 10201607521PA SG 10201607521P A SG10201607521P A SG 10201607521PA SG 10201607521P A SG10201607521P A SG 10201607521PA SG 10201607521P A SG10201607521P A SG 10201607521PA
- Authority
- SG
- Singapore
- Prior art keywords
- bat
- generation
- adipose tissue
- mesenchymal cells
- brown adipose
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0653—Adipocytes; Adipose tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
- C12N2506/1353—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261609456P | 2012-03-12 | 2012-03-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201607521PA true SG10201607521PA (en) | 2016-10-28 |
Family
ID=49161581
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201405257WA SG11201405257WA (en) | 2012-03-12 | 2013-03-12 | Generation of brown adipose tissue (bat) from mesenchymal cells |
SG10201607521PA SG10201607521PA (en) | 2012-03-12 | 2013-03-12 | Generation of brown adipose tissue (bat) from mesenchymal cells |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201405257WA SG11201405257WA (en) | 2012-03-12 | 2013-03-12 | Generation of brown adipose tissue (bat) from mesenchymal cells |
Country Status (5)
Country | Link |
---|---|
US (2) | US20150030662A1 (en) |
EP (1) | EP2825638A4 (en) |
CN (1) | CN104350146A (en) |
SG (2) | SG11201405257WA (en) |
WO (1) | WO2013137826A1 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG10201601853XA (en) | 2011-03-11 | 2016-04-28 | Univ Singapore | Pericyte progenitors from peripheral blood |
US20150216935A1 (en) * | 2012-08-09 | 2015-08-06 | Brown University | Autologous Cell-Based Therapy for Treating Obesity |
US11419916B2 (en) | 2012-09-11 | 2022-08-23 | Energesis Pharmaceuticals, Inc. | Methods and compositions for inducing differentiation of human brown adipocyte progenitors |
EP3110946B1 (en) * | 2014-02-24 | 2021-09-01 | Energesis Pharmaceuticals Inc. | Methods and compositions for inducing differentiation of human brown adipocyte progenitors |
CN108495930A (en) * | 2015-08-07 | 2018-09-04 | 京都府公立大学法人 | The preparation method of brown fat cell |
US10085963B2 (en) * | 2015-11-10 | 2018-10-02 | Sami Labs Limited | Process and compositions for achieving mammalian energy balance |
EP3387112A4 (en) * | 2015-12-07 | 2019-08-21 | BioTime, Inc. | Methods for the re-derivation of diverse pluripotent stem cell-derived brown fat cells |
NL2015957B1 (en) | 2015-12-14 | 2017-06-29 | Scala Pharma B V | Compositions and methods for inducing beige or brown fat tissue. |
CN108472319B (en) * | 2016-01-19 | 2021-12-28 | 国立大学法人大阪大学 | Transplantation material for treating heart disease |
WO2017198071A1 (en) * | 2016-05-20 | 2017-11-23 | 国立东华大学 | Applications of butylidenephthalide |
WO2017223457A1 (en) * | 2016-06-24 | 2017-12-28 | The Brigham And Women's Hospital, Inc. | Generation of brown adipose tissue from pluripotent stem cells in vitro |
CN106754664B (en) * | 2016-12-26 | 2020-09-11 | 广州赛莱拉干细胞科技股份有限公司 | Culture medium for inducing adipogenic differentiation of skeletal muscle myogenic stem cells, application of culture medium and adipogenic differentiation method |
CN110709091A (en) | 2017-05-15 | 2020-01-17 | 干细胞医药有限公司 | Treatment of multiple sclerosis using long-acting glatiramer and adipose derived stem cells |
US11510946B2 (en) | 2017-05-15 | 2022-11-29 | Stem Cell Medicine Ltd. | Treatment of multiple sclerosis with adipose-derived stem cells |
CN107384855A (en) * | 2017-07-24 | 2017-11-24 | 陈强 | A kind of induced fibroblast is the method for adipocyte like cell |
WO2019055594A1 (en) * | 2017-09-13 | 2019-03-21 | North Carolina State University | Locally-induced adipose tissue browning by microneedle patch for obesity treatment |
CN109666660A (en) * | 2017-10-13 | 2019-04-23 | 浙江工商大学 | A method of improving pancreatic lipase catalytic efficiency |
US20200368174A1 (en) * | 2018-02-21 | 2020-11-26 | Texas Tech University System | Particles for targeted delivery of active agents into adipose stromal cells |
US20220079993A1 (en) * | 2019-01-08 | 2022-03-17 | University Of Georgia Research Foundation, Inc. | Non-naturally occurring thermogenic adipocytes, methods of making, and methods of use thereof |
CN112007025B (en) * | 2019-05-30 | 2022-04-19 | 义慧科技(深圳)有限公司 | Application of mirabegron in preparation of medicine for preventing and/or treating malignant tumor |
WO2021106698A1 (en) * | 2019-11-25 | 2021-06-03 | 株式会社片岡製作所 | Composition for medium |
CN111748521B (en) * | 2020-07-14 | 2023-11-03 | 泸州君益生物医学研究有限公司 | Preparation method for increasing glucose uptake of adipose-derived mesenchymal stem cells |
CN113069440A (en) * | 2021-04-08 | 2021-07-06 | 澳门大学 | Novel application of thyroxine, method for culturing pluripotent stem cells and culture medium |
CN113481270B (en) * | 2021-06-08 | 2023-07-04 | 中国科学院海洋研究所 | Method for extracting glycopeptide from scallop skirt |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6153432A (en) * | 1999-01-29 | 2000-11-28 | Zen-Bio, Inc | Methods for the differentiation of human preadipocytes into adipocytes |
WO2006130690A2 (en) * | 2005-06-01 | 2006-12-07 | Joslin Diabetes Center, Inc. | Methods and compositions for inducing brown adipogenesis |
CA2763548C (en) * | 2008-05-27 | 2019-01-15 | Energesis Pharmaceuticals, Inc. | Brown adipocyte progenitors in human skeletal muscle |
FR2932818B1 (en) * | 2008-06-23 | 2015-12-04 | Centre Nat Rech Scient | HUMAN BROWN ADIPOCYTE LINE AND DIFFERENTIATION METHOD FROM HMADS CELL LINE. |
CA2791846A1 (en) * | 2010-03-02 | 2011-09-09 | National University Of Singapore | Culture additives to boost stem cell proliferation and differentiation response |
WO2012031015A1 (en) * | 2010-09-01 | 2012-03-08 | The Regents Of The University Of California | Cell culture screen for agents that control adipogenesis and myofibroblast differentiation |
-
2013
- 2013-03-12 EP EP13761471.5A patent/EP2825638A4/en not_active Withdrawn
- 2013-03-12 SG SG11201405257WA patent/SG11201405257WA/en unknown
- 2013-03-12 SG SG10201607521PA patent/SG10201607521PA/en unknown
- 2013-03-12 WO PCT/SG2013/000102 patent/WO2013137826A1/en active Application Filing
- 2013-03-12 US US14/384,565 patent/US20150030662A1/en not_active Abandoned
- 2013-03-12 CN CN201380013903.7A patent/CN104350146A/en active Pending
-
2017
- 2017-02-27 US US15/443,842 patent/US20170266237A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2013137826A1 (en) | 2013-09-19 |
EP2825638A4 (en) | 2015-11-25 |
US20150030662A1 (en) | 2015-01-29 |
US20170266237A1 (en) | 2017-09-21 |
SG11201405257WA (en) | 2014-09-26 |
EP2825638A1 (en) | 2015-01-21 |
CN104350146A (en) | 2015-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201607521PA (en) | Generation of brown adipose tissue (bat) from mesenchymal cells | |
HK1212388A1 (en) | Methods of tissue generation | |
HK1212261A1 (en) | Methods of tissue generation | |
HK1199905A1 (en) | Culturing of mesenchymal stem cells | |
IL238024A0 (en) | Methods of host cell modification | |
PT3527584T (en) | Medical use of cells comprising anti-ny-eso-1 t cell receptors | |
SG11201407626QA (en) | Umbilical cord mesenchymal stem cell exosomes | |
EP2872184A4 (en) | Use of cart19 to deplete normal b cells to induce tolerance | |
IL223527B (en) | Generation of induced pluripotent stem cells from small volumes of peripheral blood | |
EP2844738A4 (en) | Generating pluripotent cells de novo | |
HK1205759A1 (en) | Treatment of biomass | |
EP3190186C0 (en) | Expression of mirnas in placental tissue | |
EP2798058A4 (en) | Methods and compositions for the clinical derivation of an allogenic cell and therapeutic uses | |
EP2859356A4 (en) | Pathways characterization of cells | |
IL221664A0 (en) | Bipolar battery | |
EP2912166A4 (en) | Methods of producing pluripotent stem cells from chondrocytes | |
HK1209656A1 (en) | Generation of cartilage ex vivo from fibroblasts | |
HK1199149A1 (en) | Flexible electrode of an electrochemical cell | |
GB201217016D0 (en) | Parallel charging & discharging of multiple batteries | |
SG11201502214PA (en) | Adipose tissue cells | |
EP2900691A4 (en) | Generation of new pancreatic beta cells | |
EP2806822A4 (en) | Generation of photoreceptors from human retinal progenitor cells using polycaprolactone substrates | |
HK1198739A1 (en) | Adipose tissue-derived stem cells for veterinary use | |
EP2785380A4 (en) | Treatment of b cell lymphomas | |
GB201216933D0 (en) | Adipose tissue cells |